Androgen Insensitivity Syndrome (AIS)

Androgen Insensitivity Syndrome (AIS): The Disconnect Between Genetics and Hormones

Androgen Insensitivity Syndrome (AIS)

Androgen Insensitivity Syndrome (AIS): The Disconnect Between Genetics and Hormones

Discover the essentials of Androgen Insensitivity Syndrome (AIS). Learn about genetic causes, types like complete and partial AIS, and the clinical impact of this condition.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Overview and Definition

What Is Androgen Insensitivity Syndrome?

Androgen Insensitivity Syndrome (AIS) is a rare intersex condition that affects sexual development before birth and during puberty. It occurs in individuals who have one X and one Y chromosome (the typical genetic makeup for males) but whose bodies are unable to respond to male sex hormones called androgens. Because the body “ignores” these hormonal signals, the physical development may follow a female path despite the presence of a Y chromosome and male-typical genetic instructions.

Understanding Complete and Partial AIS

The clinical presentation of androgen insensitivity syndrome varies significantly based on the degree of hormone resistance.

Complete Androgen Insensitivity Syndrome (CAIS): The body is entirely unresponsive to androgens. At birth, these individuals have typical female external genitalia and are usually raised as girls, often remaining undiagnosed until they fail to begin menstruation.
Partial Androgen Insensitivity Syndrome (PAIS): The body has a limited response to androgens. This can result in external genitalia that appear in a spectrum between typical male and female presentations.
At Liv Hospital, we provide a multidisciplinary approach to AIS, ensuring that genetic, hormonal, and psychological aspects are managed with sensitivity and expertise.

Symptoms and Hormonal

Identifying Symptoms of AIS

The symptoms of androgen insensitivity syndrome depend on the severity of the condition. In complete androgen insensitivity syndrome, the person has female external features but lacks a uterus and ovaries. Puberty usually involves breast development (as some androgens are converted into estrogen) but very little or no pubic and underarm hair. In contrast, partial androgen insensitivity syndrome may present with an enlarged clitoris or a small penis with hypospadias (the opening of the urethra is on the underside).

Hormonal Markers and DHEA-S

Clinical diagnosis involves analyzing the “Hormonal Profile.” Individuals with AIS often have testosterone and LH (luteinizing hormone) levels that are high or at the upper limit of the male range, as the body keeps producing them in a futile attempt to get a response. We also monitor DHEA-S (Dehydroepiandrosterone sulfate), a precursor hormone. While DHEA-S levels are typically normal or elevated, they help clinicians differentiate AIS from other adrenal or gonadal issues that might mimic the condition.

Diagnosis and Evaluation

Clinical Diagnostic Pathway

The diagnostic journey for AIS often begins in infancy (due to unusual genitalia or a hernia) or at puberty (due to primary amenorrhea). At Liv Hospital, we perform a comprehensive physical exam to assess the vaginal length and external structures. For partial androgen insensitivity syndrome, the evaluation is more complex, as the physical presentation can vary widely.

Genetic Testing and Imaging

Karyotyping: A blood test that confirms the genetic sex. In AIS, the result will show 46,XY.
Genetic Sequencing: Looking for mutations in the AR (Androgen Receptor) gene on the X chromosome.
Ultrasound/MRI: These imaging tools are used to locate the internal testes and confirm the absence of a uterus, cervix, and ovaries.
Hormonal Blood Work: Measuring testosterone, LH, FSH, and DHEA-S to see how the endocrine system is functioning.

Treatment and Management

Managing AIS Through the Life Stages

Treatment for androgen insensitivity syndrome is highly personalized. In the past, surgeries were performed in infancy, but modern clinical guidelines at Liv Hospital prioritize the patient’s autonomy.

Hormone Replacement Therapy (HRT): After puberty, or if the testes are removed, estrogen therapy is essential to maintain bone density and heart health.
Vaginal Dilatation: Non-surgical methods (using dilators) can help lengthen the vagina to allow for comfortable sexual intercourse if the patient desires.

The Question of Gonadectomy

A major decision in AIS management is whether to remove the internal testes (gonadectomy). While there is a risk of these tissues becoming cancerous (germ cell tumors), this risk is very low before adulthood. Many clinicians now recommend waiting until after puberty so the patient can benefit from the natural conversion of testosterone to estrogen, which supports bone growth. After puberty, a laparoscopic removal is often discussed to eliminate the long-term cancer risk.

Lifestyle and Prevention

Living Well with Androgen Insensitivity Syndrome

Most people with Androgen Insensitivity Syndrome live healthy, fulfilling lives. The focus of long-term care is on bone health and psychological well-being. Because the body lacks the protective effects of androgens and may have lower-than-typical estrogen levels if the testes are removed, monitoring for osteoporosis is essential.

Lifestyle and Long-Term Care Tips

Prioritize Bone Density: Ensure adequate intake of Calcium and Vitamin D. Weight-bearing exercises (walking, dancing, light weights) are critical to keep bones strong.
Consistent HRT: If you have had your gonads removed, staying consistent with estrogen therapy is the best way to prevent early menopause symptoms and bone thinning.
Join a Support Group: Connecting with others who have AIS or complete androgen insensitivity syndrome can provide invaluable community and emotional support.
Regular Clinical Check-ups: Annual visits to an endocrinologist and a gynecologist familiar with DSD are important for monitoring health markers.

Why Choose Liv Hospital?

Liv Hospital provides a compassionate, world-class center for the management of Androgen Insensitivity Syndrome. Our multidisciplinary team includes expert endocrinologists, geneticists, gynecologists, and psychologists who work together to provide a seamless care experience. We understand the complexity of an AIS diagnosis and prioritize a patient-centered approach that respects identity and autonomy. Whether you are seeking a first-time diagnosis or long-term management, we are here to support your journey. We encourage you to reach out and call Liv Hospital to learn how our specialized team can provide the care and clarity you deserve.

Book a Free Certified Online
Doctor Consultation

Related Doctors

Liv Hospital Ulus Assoc. Prof. MD. Seda Turgut Endocrinology and Metabolism

Liv Hospital Ulus Prof. MD. Demet Yetkin Endocrinology and Metabolism

Liv Hospital Vadistanbul Prof. MD. Berçem Ayçiçek Endocrinology and Metabolism

Liv Hospital Vadistanbul Prof. MD. Gönül Çatlı Pediatric Endocrinology

Liv Hospital Vadistanbul Prof. MD. Kubilay Ükinç Endocrinology and Metabolism

Liv Hospital Bahçeşehir Assoc. Prof. MD. Sevil Arı Yuca Pediatric Endocrinology and Metabolic Diseases

Liv Hospital Bahçeşehir Assoc. Prof. MD. Ufuk Özuğuz Endocrinology and Metabolism

Liv Hospital Bahçeşehir Spec. MD. Hüseyin Çelik Endocrinology and Metabolism

Liv Hospital Topkapı Prof. MD. Mehmet Aşık Endocrinology and Metabolism

Liv Hospital Topkapı Prof. MD. Nujen Çolak Bozkurt Endocrinology and Metabolism

Liv Hospital Ankara Prof. MD. Banu Aktaş Yılmaz Endocrinology and Metabolism

Liv Hospital Ankara Prof. MD. Peyami Cinaz Pediatric Endocrinology

Liv Hospital Ankara Prof. MD. Serdar Güler Endocrinology and Metabolism

Liv Hospital Ankara Spec. MD. Elif Sevil Alagüney Endocrinology and Metabolism

Liv Hospital Gaziantep Prof. MD. Zeynel Beyhan Endocrinology and Metabolic Diseases

Liv Hospital Gaziantep Spec. MD. Tahsin Özenmiş Endocrinology and Metabolism

Liv Hospital Samsun Assoc. Prof. MD. Gülçin Cengiz Ecemiş Endocrinology and Metabolism

Liv Hospital Samsun Spec. MD. Esra Tutal Endocrinology and Metabolic Diseases

Liv Bona Dea Hospital Bakü MD. FİDAN QULU Endocrinology and Metabolism

Spec. MD. Zümrüt Kocabey Sütçü Pediatric Endocrinology

Liv Hospital Ulus + Liv Hospital Vadistanbul + Liv Hospital Topkapı Prof. MD. Cengiz Kara Pediatric Endocrinology

30 Years of Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Reviews from 9,651

4,9

Worth a look

Was this article helpful?

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

FREQUENTLY ASKED QUESTIONS

Is AIS a common condition?

No; it is estimated to affect approximately 1 in 20,000 to 50,000 genetically male births.

Can individuals with AIS have children?

Individuals with complete androgen insensitivity syndrome do not have a uterus and are infertile, though they can pursue parenthood through adoption or other family-building options.

Is AIS a disease?

It is classified as a “disorder of sex development” (DSD) or a variation in biological sex, rather than an illness that needs to be “cured.”

Where are the testes located in AIS?

The testes usually remain inside the abdomen or the inguinal canal because they do not descend during development.

Is the life expectancy normal?

Yes; individuals with androgen insensitivity syndrome have a normal life expectancy.